Added to YB: 2024-09-11
Pitch date: 2024-09-10
CLPT [bearish]
ClearPoint Neuro, Inc.
-2.4%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
Market Cap
$438.6M
Pitch Price
$12.09
Price Target
6.00 (-53%)
Dividend
N/A
EV/EBITDA
-20.80
P/E
-18.67
EV/Sales
12.70
Sector
Health Care Equipment and Supplies
Category
value
$CLPT Short idea -- PT ~6/sh downside 50%
CLPT short: Overvalued at 10x P/S vs. 5x fair value. Weak fundamentals: 23% rev CAGR, declining margins, negative EBITDA/EPS/CFO, share dilution. Hype-driven 120% surge on partner data & earnings, but no real catalysts. OR & LITT products face tough competition. $6 PT.
Read full article (3 min)